MARKER THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
MARKER THERAPEUTICS, INC. (MRKR) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -0.11% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2025-03-31
- MARKER THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -0.11%.
- MARKER THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -32.14%.
- MARKER THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was -5.15%.
- MARKER THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was -0.25%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | -0.11% 10-K · filed 2025-03-31 | |
| 2023-12-31 | -32.14% 10-K · filed 2024-03-26 | |
| 2022-12-31 | -5.15% 10-K · filed 2024-03-26 | -3.40% 10-K · filed 2023-03-22 |
| 2021-12-31 | -0.25% 10-K · filed 2023-03-22 | |
| 2020-12-31 | -0.83% 10-K · filed 2022-03-17 | |
| 2019-12-31 | 1.28% 10-K · filed 2021-03-09 | |
| 2018-12-31 | 0.00% 10-K · filed 2020-03-12 | |
| 2017-12-31 | 0.44% 10-K · filed 2019-03-15 | 0.50% 10-K · filed 2018-03-23 |
| 2016-12-31 | 5.20% 10-K · filed 2018-03-23 | |
| 2015-12-31 | 1.00% 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |